Aldosterone antagonist combined with a SGLT2 inhibitor versus SGLT2 inhibitor monotherapy: An updated meta-analysis. - Mendonça L; Neves JS; Vasques-Nóvoa F; Leite AR; Marques P; Ferreira JP (Diabetes, obesity & metabolism, 2026)